Comments to FDA: International Scheduling Recommendations for Dronabinol and its Stereoisomers, Cannabidiol Preparations, and Pharmaceutical Preparations of Cannabis

Comments | Mar 14, 2019

Docket Number:

FDA-2019-N-0767

CHPA has reviewed the findings of the meeting of the World Health Organization Expert Committee on Drug Dependence. CHPA agrees with the Committee's recommendations.

Download Document

Issues:

Dietary Supplements

CBD and Hemp Oil

Comments to FDA: International Scheduling Recommendations for Dronabinol and its Stereoisomers, Cannabidiol Preparations, and Pharmaceutical Preparations of Cannabis

Related Posts